Citius Oncology, Inc.
Cash Flow Statement
| Line Item | Jun 2023 | Mar 2023 |
|---|---|---|
| Operating Activities | ||
| Net Income | $616.3K | $611.7K |
| Depreciation & Amortization | — | — |
| Depreciation | — | — |
| Amortization | — | — |
| Stock-Based Compensation | — | — |
| Net Cash from Operating Activities | $-100.3K | $-168.8K |
| Investing Activities | ||
| Capital Expenditures | — | — |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | — | — |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | — | — |
| Net Change in Cash | $249.7K | $-168.8K |
| Free Cash Flow | — | — |